Josie Ford
IN 2016, the UN issued its “Political Declaration on Ending AIDS“, aiming to rid the world of the HIV epidemic by 2030. One target for 2020 was to reduce new HIV infections to fewer than 500,000 by, among other things, reaching 3 million at-risk people with pre-exposure prophylaxis (PrEP) by this year. But this target is set to be missed by a country mile, hindering the global fight.
PrEP is a pill containing two chemicals, tenofovir and emtricitabine, that kills HIV before it can infect a person. It can be taken either daily, or at specific times prior …
